Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

Similar articles for PubMed (Select 21715474)


The cytoplasmic domain of rhesus cytomegalovirus Rh178 interrupts translation of major histocompatibility class I leader peptide-containing proteins prior to translocation.

Richards R, Scholz I, Powers C, Skach WR, Früh K.

J Virol. 2011 Sep;85(17):8766-76. doi: 10.1128/JVI.05021-11. Epub 2011 Jun 29.


Signal peptide-dependent inhibition of MHC class I heavy chain translation by rhesus cytomegalovirus.

Powers CJ, Früh K.

PLoS Pathog. 2008 Oct 3;4(10):e1000150. doi: 10.1371/journal.ppat.1000150.


Rhesus cytomegalovirus contains functional homologues of US2, US3, US6, and US11.

Pande NT, Powers C, Ahn K, Früh K.

J Virol. 2005 May;79(9):5786-98.


Ubiquitinylation of the cytosolic domain of a type I membrane protein is not required to initiate its dislocation from the endoplasmic reticulum.

Furman MH, Loureiro J, Ploegh HL, Tortorella D.

J Biol Chem. 2003 Sep 12;278(37):34804-11. Epub 2003 Jun 27.


Inhibition of the MHC class II antigen presentation pathway by human cytomegalovirus.

Johnson DC, Hegde NR.

Curr Top Microbiol Immunol. 2002;269:101-15. Review.


The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP.

Ahn K, Gruhler A, Galocha B, Jones TR, Wiertz EJ, Ploegh HL, Peterson PA, Yang Y, Früh K.

Immunity. 1997 May;6(5):613-21.


The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation.

Lehner PJ, Karttunen JT, Wilkinson GW, Cresswell P.

Proc Natl Acad Sci U S A. 1997 Jun 24;94(13):6904-9.


Human cytomegalovirus inhibits peptide translocation into the endoplasmic reticulum for MHC class I assembly.

Hengel H, Flohr T, Hämmerling GJ, Koszinowski UH, Momburg F.

J Gen Virol. 1996 Sep;77 ( Pt 9):2287-96.


Binding of human cytomegalovirus US2 to major histocompatibility complex class I and II proteins is not sufficient for their degradation.

Chevalier MS, Daniels GM, Johnson DC.

J Virol. 2002 Aug;76(16):8265-75. Erratum in: J Virol 2002 Dec;76(24):13126.


Human cytomegalovirus UL18 utilizes US6 for evading the NK and T-cell responses.

Kim Y, Park B, Cho S, Shin J, Cho K, Jun Y, Ahn K.

PLoS Pathog. 2008 Aug 8;4(8):e1000123. doi: 10.1371/journal.ppat.1000123.


The HCMV gene products US2 and US11 target MHC class I molecules for degradation in the cytosol.

van der Wal FJ, Kikkert M, Wiertz E.

Curr Top Microbiol Immunol. 2002;269:37-55. Review.


The C-terminal amino acid of the MHC-I heavy chain is critical for binding to Derlin-1 in human cytomegalovirus US11-induced MHC-I degradation.

Cho S, Kim BY, Ahn K, Jun Y.

PLoS One. 2013 Aug 12;8(8):e72356. doi: 10.1371/journal.pone.0072356. eCollection 2013.


Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction.

Wiertz EJ, Tortorella D, Bogyo M, Yu J, Mothes W, Jones TR, Rapoport TA, Ploegh HL.

Nature. 1996 Dec 5;384(6608):432-8.


Human cytomegalovirus-encoded US2 differentially affects surface expression of MHC class I locus products and targets membrane-bound, but not soluble HLA-G1 for degradation.

Barel MT, Ressing M, Pizzato N, van Leeuwen D, Le Bouteiller P, Lenfant F, Wiertz EJ.

J Immunol. 2003 Dec 15;171(12):6757-65.


Human cytomegalovirus disrupts the major histocompatibility complex class I peptide-loading complex and inhibits tapasin gene transcription.

Halenius A, Hauka S, Dölken L, Stindt J, Reinhard H, Wiek C, Hanenberg H, Koszinowski UH, Momburg F, Hengel H.

J Virol. 2011 Apr;85(7):3473-85. doi: 10.1128/JVI.01923-10. Epub 2011 Jan 19.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk